• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    United States Antimony Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    4/28/25 3:55:56 PM ET
    $UAMY
    Metal Fabrications
    Industrials
    Get the next $UAMY alert in real time by email
    uamy_8k.htm
    0000101538false00001015382025-04-252025-04-25iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

     

    Date of report (Date of earliest event reported) April 25, 2025

     

    UNITED STATES ANTIMONY CORPORATION

    (Exact name of registrant as specified in its charter)

     

    Montana

     

    001-08675

     

    81-0305822

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File No.)

     

    (IRS Employer

    Identification Number)

     

    4438 W. Lover’s Lane, Unit 100, Dallas, TX

     

    75209

    (Address of principal executive officers)

     

    (Zip Code)

     

    Registrant’s telephone number, including area code: (406) 606-4117

     

    Not Applicable

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading Symbol(s)

     

    Name of each exchange on which registered

    Common Stock, $0.01 par value

     

    UAMY

     

    NYSE American

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

        

    Item 8.01 Other Events.

     

    On April 25, 2025, United States Antimony Corporation (the “Company”) filed a prospectus supplement with the Securities and Exchange Commission to the Company’s Registration Statement on Form S-3 (No. 333-284057), registering shares of the Company’s common stock, par value $0.01, issuable pursuant to the Sales Agreement dated November 12, 2024 between the Company and A.G.P./Alliance Global Partners.

     

    An opinion and consent of Hall Booth Smith, P.C. with respect to the validity of the shares of common stock that may be sold under the Sales Agreement is filed herewith as Exhibit 5.1.

     

    This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit No.

     

    Description

     

     

     

    5.1

     

    Opinion of Hall Booth Smith, P.C.

    23.1

     

    Consent of Hall Booth Smith, P.C. (included in Exhibit 5.1)

    104

     

    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     

     

    UNITED STATES ANTIMONY CORPORATION

     

     

     

     

    April 28, 2024

    By:

    /s/ Richard R. Isaak

     

     

    Richard R. Isaak

    SVP, Chief Financial Officer

     

     

     

    3

     

     

    Get the next $UAMY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UAMY

    DatePrice TargetRatingAnalyst
    3/21/2025$3.00Buy
    B. Riley Securities
    12/10/2024$2.50Buy
    H.C. Wainwright
    More analyst ratings